Market Report, "Promyco Diagnostics Ltd. - Product Pipeline Analysis, 2013 Update", published

From: Fast Market Research, Inc.
Published: Thu Dec 05 2013

Promyco Diagnostics Ltd. (Promyco) is a medical device company. The company develops diagnostics kits for the detection of genital mycoplasma infections. Promyco's products include ureaplasma serology kit, mycoplasma hominis serology kit, mycoplasma genitalium serology kit and mycoplasma fermentans detection kit. Its ureaplasma serology kit is used for detection of antibodies to ureaplasma urealyticum and ureaplasma parvum in human serum or other body fluids; mycoplasma hominis serology kit is an immunological kit for the detection of antibody response to M. hominis infection. The company's research laboratories are located at Soroka UniversityMedical Center, Zeer Sheba, Israel. Promyco is headquartered in Jerusalem, Israel.

Full Report Details at

This report is a source for data, analysis and actionable intelligence on the Promyco Diagnostics Ltd. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.


* Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
* Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
* Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
* Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
* Data on relevant clinical trials and product patent details, wherever applicable.
* Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Get this Report

* Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Siemens Healthcare Diagnostics Inc. - Product Pipeline Analysis, 2013 Update
- Chembio Diagnostics, Inc. (CEMI) - Product Pipeline Analysis, 2013 Update
- SQI Diagnostics Inc. (SQD) - Product Pipeline Analysis, 2013 Update
- Abbott Diagnostics - Product Pipeline Analysis, 2013 Update
- Roche Diagnostics Limited - Product Pipeline Analysis, 2013 Update
Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email:
Contact Phone: 1-413-485-7001

Visit website »